NEOVACS SA (UK) Performance


EUR 0.19  0.005  2.70%   

The company secures a Beta (Market Risk) of -0.4373, which conveys possible diversification benefits within a given portfolio. Let's try to break down what NEOVACS's beta means in this case. As returns on the market increase, returns on owning NEOVACS SA are expected to decrease at a much lower rate. During the bear market, NEOVACS SA is likely to outperform the market. Although it is important to respect NEOVACS SA NEOVACS price patterns, it is better to be realistic regarding the information on the equity's historical price patterns. The approach towards estimating future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By inspecting NEOVACS SA NEOVACS technical indicators, you can now evaluate if the expected return of 0.0% will be sustainable into the future. NEOVACS SA NEOVACS currently secures a risk of 0.0%. Please verify NEOVACS SA NEOVACS downside deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance to decide if NEOVACS SA NEOVACS will be following its current price movements.
NEOVACS Performance
0 of 100
Over the last 90 days NEOVACS SA NEOVACS has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively steady basic indicators, NEOVACS SA is not utilizing all of its potentials. The current stock price chaos, may contribute to medium-term losses for the stakeholders. ...more
Quick Ratio20.57
Fifty Two Week Low0.2115
Fifty Two Week High0.2115

NEOVACS SA Relative Risk vs. Return Landscape

If you would invest  19.00  in NEOVACS SA NEOVACS on May 20, 2022 and sell it today you would earn a total of  0.00  from holding NEOVACS SA NEOVACS or generate 0.0% return on investment over 90 days. NEOVACS SA NEOVACS is producing return of less than zero assuming 0.0% volatility of returns over the 90 days investment horizon. Simply put, 0% of all stocks have less volatile historical return distribution than NEOVACS SA, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Daily Expected Return (%)  
       Risk (%)  

NEOVACS SA Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for NEOVACS SA's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as NEOVACS SA NEOVACS, and traders can use it to determine the average amount a NEOVACS SA's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Good Returns
Average Returns
Small Returns
Based on monthly moving average NEOVACS SA is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NEOVACS SA by adding it to a well-diversified portfolio.

About NEOVACS SA Performance

To evaluate NEOVACS SA NEOVACS Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when NEOVACS SA generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare NEOVACS Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand NEOVACS SA NEOVACS market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents NEOVACS's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. Neovacs S.A. was founded in 1993 and is based in Paris, France. NEOVACS SA is traded on London Stock Exchange in UK.

Things to note about NEOVACS SA NEOVACS

Checking the ongoing alerts about NEOVACS SA for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for NEOVACS SA NEOVACS help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.


Equity Alerts and Improvement Suggestions

NEOVACS SA NEOVACS is not yet fully synchronised with the market data
NEOVACS SA NEOVACS has some characteristics of a very speculative penny stock
NEOVACS SA NEOVACS has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 90.52 K. Net Loss for the year was (2.88 M) with loss before overhead, payroll, taxes, and interest of (1.69 M).
NEOVACS SA NEOVACS has accumulated about 35.78 M in cash with (6.65 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 100.49, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Please continue to Trending Equities. Note that the NEOVACS SA NEOVACS information on this page should be used as a complementary analysis to other NEOVACS SA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Tools for NEOVACS Stock

When running NEOVACS SA NEOVACS price analysis, check to measure NEOVACS SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NEOVACS SA is operating at the current time. Most of NEOVACS SA's value examination focuses on studying past and present price action to predict the probability of NEOVACS SA's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move NEOVACS SA's price. Additionally, you may evaluate how the addition of NEOVACS SA to your portfolios can decrease your overall portfolio volatility.
Bond Directory
Find actively traded corporate debentures issued by US companies
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios